Breaking News
Sort by:
Top Post
Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure
Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), today announced it […]
Abbott Confirms Capacity to Support Expanded Use of HeartMate 3™ Heart Pump
Abbott today announced the company has capacity and supply to effectively support the growing demand […]
Portable ECG Device to be Further Rolled Out After Successful Pilot
A portable ECG monitoring device that detects heart irregularities is to be rolled out across […]
Royal Free Patient First to Receive Smartphone Connected Defibrillator
A 61-year-old year old man has become the first patient at the Royal Free London […]
New Research to Study Benefits of Personalised Pacemaker Programming
Researchers BHF have funded at the University of Leeds will investigate how people living with […]
3D Heart Scans to Give Faster Treatment
People in England with coronary heart disease will be seen, diagnosed and treated up to […]
Abbott New Trial Seeks Better Treatment for AFib and Heart Failure
Abbott (NYSE: ABT) today announced a new trial focused on improving the treatment for people simultaneously […]
Glowing Probe Could Diagnose Cardiovascular Disease Earlier
Researchers have created a probe that glows when it detects an enzyme associated with issues […]
GEN inCode Announces Major UK Collaboration
GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention […]
Peijia Medical TaurusOne® Approved for Commercialization
A new interventional solution from China for structural heart disease is about to be launched onto the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more